MedTrace Logo

Diabetes and Psoriasis

NCT02366273 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 425

Last updated 2022-05-24

No results posted yet for this study

Summary

Patients with psoriasis will be evaluated. The investigators will collect personal history, concomitant diseases and in particular the presence of type 2 diabetes mellitus, impaired fasting glucose and impaired glucose tollerance. The aim of the study will be to evaluate if there is a correlation among inflammation, insulin-resistance and psoriasis.

Conditions

Interventions

OTHER

PASI and HOMA index

Sponsors & Collaborators

  • Fondazione IRCCS Policlinico San Matteo di Pavia

    collaborator OTHER

  • University of Pavia

    lead OTHER

Principal Investigators

  • Giuseppe Derosa, MD, PhD, FESC · University of Pavia - IRCCS Policlinico San Matteo Foundation

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-01
Primary Completion
2018-02-28
Completion
2018-06-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02366273 on ClinicalTrials.gov